Tratamiento con rifampicina del prurito refractario de origen neoplásico no colestásico. A propósito de dos casos / Treatment of non-cholestatic refractory neoplasic pruritus with rifampicin. About two cases
Med. paliat
; 12(2): 70-73, abr.-jun. 2005. ilus, tab
Article
in Es
| IBECS
| ID: ibc-040385
Responsible library:
ES1.1
Localization: ES1.1 - BNCS
RESUMEN
El prurito es un síntoma poco frecuente en medicina paliativa que puede afectar seriamente la calidad de vida de los pacientes. Presentamos dos casos clínicos de prurito no colestásico resistentes a los tratamientos convencionales y que cedieron de forma clara y dosis dependiente a tratamiento con rifampicina. En los dos casos, cedió con dosis mayores que las empleadas en el prurito colestásico, existiendo un fenómeno de tolerancia con la evolución dela enfermedad que obligó a sucesivos incrementos de dosis para mantener el efecto deseado (AU)
ABSTRACT
The pruritus is an infrequent symptom in palliative medicine that can affect seriously the quality of life of the patients. We present two clinical cases of pruritus not cholestasis, resistant to the conventional treatments, controlled cleared and dose dependent with rifampicin.In both cases, the pruritus disappears with higher doses that are normally used in cholestatic pruritus, creating a phenomenon of tolerance with the evolution of the disease that forced to successive increases of dose to maintain the desired effect (AU)
Search on Google
Collection:
National databases
/
Spain
Database:
IBECS
Main subject:
Pruritus
/
Rifampin
/
Skin Neoplasms
Type of study:
Etiology study
Aspects:
Patient-preference
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
Language:
Spanish
Journal:
Med. paliat
Year:
2005
Document type:
Article
Institution/Affiliation country:
Fundación CUDECA/España